Functional polymorphism 57Val>Ile of aurora kinase A associated with increased risk of gastric cancer progression

Cancer Letters

Volumn 242, Issue 2, 2006, Pages 273-279

  Ju, Hyoungseok ^a   Cho, Hyunmi ^a   Kim, Yong Sung ^b   Kim, Woo Ho ^c   Ihm, Chunhwa ^d   Noh, Seung Moo ^e   Kim, Jin Bok ^f   Hahn, Dong Soo ^g   Choi, Bo Yuol ^h   Kang, Changwon ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Eulji University   (South Korea)

^e Chungnam National University College of Medicine   (South Korea)

^f Inje University College of Medicine   (South Korea)

^g Hanyang University Guri Hospital   (South Korea)

^h Hanyang University College of Medicine   (South Korea)

Author keywords

Advanced gastric cancer; Case control study; Disease severity association; Single nucleotide polymorphism; STK15 Aurora A BTAK

Indexed keywords

AURORA A KINASE; ISOLEUCINE TRANSFER RNA LIGASE; PHENYLALANINE; PROTEIN KINASE; VALINE;

ADULT; AGED; ALLELE; ARTICLE; CANCER GENETICS; CANCER RISK; CANCER SUSCEPTIBILITY; CHROMOSOMAL INSTABILITY; CLINICAL OBSERVATION; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRANSFORMATION; GENETIC VARIABILITY; GENOTYPE; GROUPS BY AGE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SAMPLE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STOMACH CANCER; STOMACH CARCINOGENESIS;

ALLELES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; ISOLEUCINE; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RISK; STOMACH NEOPLASMS; VALINE;

EID: 33749264040     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.11.015     Document Type: Article

References (32)

1. Zimmerman W., Sparks C.A., and Doxsey S.J. Amorphous no longer: the centrosome comes into focus. Curr. Opin. Cell Biol. 11 (1999) 122-128
2. Bischoff J.R., and Plowman G.D. The Aurora/Ipl1p kinase family: regulators of chromosome segregation and cytokinesis. Trends Cell Biol. 9 (1999) 454-459
3. Carmena M., and Earnshaw W.C. The cellular geography of aurora kinases. Nat. Rev. Mol. Cell Biol. 4 (2003) 842-854
4. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 20 (1998) 189-193
5. Sen S., Zhou H., and White R.A. A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines. Oncogene 14 (1997) 2195-2200
6. Bischoff J.R., Anderson L., Zhu Y., Mossie K., Ng L., Souza B., et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. Eur. Mol. Biol. Org. J. 17 (1998) 3052-3065
7. Sakakura C., Hagiwara A., Yasuoka R., Fujita Y., Nakanishi M., Masuda K., et al. Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation. Br. J. Cancer 84 (2001) 824-831
8. Kamada K., Yamada Y., Hirao T., Fujimoto H., Takahama Y., Ueno M., et al. Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis. Oncol. Rep. 12 (2004) 593-599
9. Sen S., Zhou H., Zhang R.D., Yoon D.S., Vakar-Lopez F., Ito S., et al. Amplification/overexpression of a mitotic kinase gene in human bladder cancer. J. Natl Cancer Inst. 94 (2002) 1320-1329
10. Honda K., Mihara H., Kato Y., Yamaguchi A., Tanaka H., Yasuda H., et al. Degradation of human Aurora2 protein kinase by the anaphase-promoting complex-ubiquitin-proteasome pathway. Oncogene 19 (2000) 2812-2819
11. Littlepage L.E., and Ruderman J.V. Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit. Genes Dev. 16 (2002) 2274-2285
12. Ewart-Toland A., Briassouli P., de Koning J.P., Mao J.H., Yuan J., Chan F., et al. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human. Nat. Genet. 34 (2003) 403-412
13. Kimura M.T., Mori T., Conroy J., Nowak N.J., Satomi S., Tamai K., et al. Two functional coding single nucleotide polymorphisms in STK15 (Aurora-A) coordinately increase esophageal cancer risk. Cancer Res. 65 (2005) 3548-3554
14. Miao X., Sun T., Wang Y., Zhang X., Tan W., and Lin D. Functional STK15 Phe31Ile polymorphism is associated with the occurrence and advanced disease status of esophageal squamous cell carcinoma. Cancer Res. 64 (2004) 2680-2683
15. Sun T., Miao X., Wang J., Tan W., Zhou Y., Yu C., et al. Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma. Carcinogenesis 25 (2004) 2225-2230
16. Egan K.M., Newcomb P.A., Ambrosone C.B., Trentham-Dietz A., Titus-Ernstoff L., Hampton J.M., et al. STK15 polymorphism and breast cancer risk in a population-based study. Carcinogenesis 25 (2004) 2149-2153
17. Dai Q., Cai Q.Y., Shu X.O., Ewart-Toland A., Wen W.Q., Balmain A., et al. Synergistic effects of STK15 gene polymorphisms and endogenous estrogen exposure in the risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 2065-2070
18. Lo Y.L., Yu J.C., Chen S.T., Yang H.C., Fann C.S., Mau Y.C., et al. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK. Int. J. Cancer 115 (2005) 276-283
19. Dicioccio R.A., Song H., Waterfall C., Kimura M.T., Nagase H., McGuire V., et al. STK15 polymorphisms and association with risk of invasive ovarian cancer. Cancer Epidemiol. Biomarkers Prev. 13 (2004) 1589-1594
20. Ewart-Toland A., Dai Q., Gao Y.T., Nagase H., Dunlop M.G., Farrington S.M., et al. Aurora-A/STK15 T+91A is a general low penetrance cancer susceptibility gene: a meta-analysis of multiple cancer types. Carcinogenesis 26 (2005) 1368-1373
21. Kimura M., Matsuda Y., Eki T., Yoshioka T., Okumura K., Hanaoka F., et al. Assignment of STK6 to human chromosome 20q13.2→q13.3 and a pseudogene STK6P to 1q41→q42. Cytogenet. Cell Genet. 79 (1997) 201-203
22. Schneider S., Roessli D., and Excoffier L. Arlequin Ver 2.000: A Software for Population Genetics Data Analysis (2000), Genetics and Biometry Laboratory, University of Geneva, Switzerland
23. Stephens M., Smith N.J., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J. Hum. Genet. 68 (2001) 978-989
24. Katayama H., Sasai K., Kawai H., Yuan Z.M., Bondaruk J., Suzuki F., et al. Phosphorylation by aurora kinase a induces Mdm2-mediated destabilization and inhibition of p53. Nat. Genet. 36 (2004) 55-62
25. Liu Q., Kaneko S., Yang L., Feldman R.I., Nicosia S.V., Chen J., et al. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215. J. Biol. Chem. 279 (2004) 52175-52182
26. Marumoto T., Zhang D., and Saya H. Aurora-A-a guardian of poles. Nat. Rev. Cancer 5 (2005) 42-50
27. Werner M., Becker K.F., Keller G., and Hofler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J. Cancer Res. Clin. Oncol. 127 (2001) 207-216
28. Lynch H.T., Grady W., Suriano G., and Huntsman D. Gastric cancer: new genetic developments. J. Surg. Oncol. 90 (2005) 114-133
29. Peek Jr. R.M., and Blaser M.J. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat. Rev. Cancer 2 (2002) 28-37
30. Gonzalez C.A., Pera G., Agudo A., Palli D., Krogh V., Vineis P., et al. Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). Int. J. Cancer 107 (2003) 629-634
31. Tsugane S., Sasazuki S., Kobayashi M., and Sasaki S. Salt and salted food intake and subsequent risk of gastric cancer among middle-aged Japanese men and women. Br. J. Cancer 90 (2004) 128-134
32. Palli D. Epidemiology of gastric cancer: an evaluation of available evidence. J. Gastroenterol. 35 Suppl. 12 (2000) 84-89